DENNIS MULROY - 30 Jan 2024 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol: ANAB
Transactions as of: 30 Jan 2024
Net transactions value: -$72,425
Form type: 4
Filing time: 01 Feb 2024, 17:27:36 UTC
Previous filing: 09 Jan 2024
Next filing: 24 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANAB	Common Stock	Sale	$72,425	-3,065	-76%	$23.63	964	30 Jan 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.325 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Content

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.325 to $23.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.